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Method: We performed a prospective observational study which aimed to
describe all patients over 75 years hospitalized in a cardiology department. For
each patient we collected cause of hospitalisation, medical and cardiovascular
history. We compared patients with and without previous history of AF (“AF
group” versus “sinus group”).
Results: Among 1050 patients admitted during an inclusion period of
4 months, 357 patients were older than 75 years: 150 in the “AF group” and
207 in the “sinus group”. AF was paroxysmal, persistent and permanent
respectively in 21%, 30%, and 48% of cases.
Table – Main data
Conclusion: Patients over 75 years of age accounted for 34% of patients
admitted in our cardiology department and 42% of them had a history of atrial
fibrillation.
AF patients had more frequently valvular disease, thyroid dysfunction,
which are comorbidities associated with AF but also more strokes, dementia
and hospitalization for heart failure which may be consequences of AF.
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The risk of atrial fibrillation (AF) in patients with paroxysmal supraventric-
ular tachycardia (SVT) is well-known. AF is a cause of embolic event and a
risk of stroke in patients with SVT can be expected. The purpose of the study
was to assess the prevalence of unexplained stroke in patients presenting with
SVT and to look for the risk factors.
Methods: Electrophysiological study (EPS) was performed in 1379 patients
without anterograde conduction through accessory pathway (AP) for SVT.
Clinical and electrophysiological data were collected.
Results: Stroke was noted in 38 patients (group I) (prevalence 2.8%).
1341 patients had no stroke (group II). 1) Clinical data: Group I was older
than group II (62±13 vs 49±19 years) (p<0.0002). Associated heart disease
(14/38, 37% vs 139/1341, 10%)(p<0.0001), AF history (4/38, 10.5%, 32/1341,
2%, p<0.002) were more frequent in group I than in group II. Male gender
was similar in both groups. 2) Electrophysiological data: SVT mechanism
was similar: AV re-entrant tachycardia in a concealed AP was noted in 4
group I patients (10.5%) and 247 group II patients (18%)(NS). Signs of atrial
vulnerability were as frequent in both groups. 3) Follow-up (mean 3±3 years):
Adverse events (AE) occurred in 102 patients: 3 group II patients presented a
stroke; AF occurred in 8 group I patients (21%), 62 group II patients
(5%)(p<0.0001); 3 group I patients (8%), 26 group II patients (2%) died from
cardiovascular death (p<0.01). SVT ablation was performed in 65 of
102 patients (64%) with AE (AF or death), 790 of 1277 patients without AE
(62%)(NS). Age (p=0.001), prior AF (p=0.001) were the 2 independent risk
factors of stroke at multivariate analysis stroke. Adjusted on age, heart disease
was not significantly associated with stroke.
Conclusions: Unexplained stroke was a rare event in patients with paro-
xysmal SVT (2.8%). Old age, and AF history were the only independent sig-
nificant factors associated with the history of stroke in these patients. They
had a risk of severe adverse events during the follow-up as spontaneous AF
(21%) or death (8%). SVT ablation did not reduce the risk of new stroke,
spontaneous AF or death.
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Introduction: Catheter ablation has emerged as a realistic therapeutic
option for symptomatic atrial fibrillation (AF). Young patients with AF are
often more symptomatic and long-term taking medication is very demanding
for their daily life. The aim of our study is to describe the safety and the long-
term effectiveness of catheter ablation of AF in patients under 30 years of age.
Methods and results: Twenty five consecutive patients < 30 years old
(mean age: 26±3; 16-29) with paroxysmal (13 pts, 52%) or persistent AF
(12 pts, 48%, AF duration 40±24 months) underwent catheter ablation of
symptomatic atrial fibrillation refractory to at least one antiarrythmic drug
(AAD), in our center. Only 3 patients had structural heart disease (hypertro-
phic cardiomyopathy). Patients were hospitalized and monitored at 3, 6 and 12
months, every 6 months thereafter and at the end of the follow up. Mean radio
frequency duration was 51±29 min (39±14 for PAF and 65±40 for PsAF) for
total procedure time of 176±91 min (128±55 for PAF and 224±100 for PsAF)
and a fluoroscopic time of 52±33 min (38±20 for PAF and 62±36 for PsAF).
In all procedures, no major complication occurred. After a mean follow up of
54 months ± 29; 21/25 (84%) patients remained arrhythmia-free (92% for
PAF and 76% for PsAF) after a mean of 1.6 procedure per patient. 19 of the
21 arrhythmia free patients were also AAD free. Only 3 patients of these
21 patients were treated with warfarin.
Conclusion: These finding suggest that catheter ablation of AF in patients
under 30 years of age is safe, with good clinical long term outcome. Catheter
ablation of AF can be first-line therapy in young people.
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TOTAL
=357
AF group 
=150 (42%)
Sinus group
=207(58%)
p
Age 82±13 83±13 81±11 0.03 
Men 186 75 (50) 106 (51.2) 0.9
HTA 178 (50) 76 (50.7) 102 (49.5) 0.9
Diabetes 86 (24.1) 35 (23.3) 51 (24.7) 0.1
Dyslipemia 93 (26.1) 35 (23.3) 58 (28.2) 0.3
Ischemic heart 
disease
13 (38.8) 55 (36.7) 83 (40.3) 0.1
Respiratory failure 26 (7.28) 13 (8.6) 13 (6.28) 0.4
Valvular heart disease 38 (10.5) 20 (13.3) 18 (8.73) 0.04
Pulmonary embolism 20 (5.6) 13 (8.6) 7 (3.3) 0.02
AVC 39 (10.9) 23 (15.3) 16 (7.7) 0,01
Thyroid disease 32 (8.9) 18 (12) 14 (6.7) 0.03
Dementia 23 (6.5) 13 (8.7) 10 (4.9) 0.1
Alcoholism 11 (3) 10 (6.7) 1 (0.48) 0.01
Main cause of
hospitalisation
   
Cardiac heart failure 111 (31) 67 (44.7) 44 (21.4) <0.001
Acute coronary 
syndrome
67 (19) 11 (7.3) 56 (26.6) <0.001 
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Introduction: Several studies proved that obstructive sleep apnea (OSA) is
associated with cardio-vascular diseases such as cardiac arrhythmia. QT dura-
tion and dispersion reflect the heterogeinity of ventricular repolarization and
are considered as precursors of ventricular arrhythmia
Aim: The aim of this study is to assess the relation between the severity of
OSA parameters as apnea hypopnea index and QT intervals.
Methods: Forty patients (18 men and 22 women) who were diagnosed
with OSA by overnight polysomnography were included in this prospective
study. The mean age was 56±10 years old. They were all in sinus rhythm.
Before initiating continuous positive airway pressure therapy, we calculated
on a 12 lead ECG : QT duration (QTend) corrected to Bazett formula and QT
dispersion (QT end max -QT end min).
Results: Twenty four patients had severe OSA (AHI >30), 4 had moderate
OSA (AHI between 15 and 30) and 12 had a mild OSA (AHI between 5 and
15). There was a significant positive correlation between QT dispersion and
AHI (r=0.48, p=0.001)
Conclusion: The severity of OSA seems to be correlated with ventricular
repolarization heterogeinity These results suggest that the higher is the AHI
the higher is the risk of ventricular arrhythmia occurence. Further studies are
needed to validate these results.
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Background: Electromechanical correlates at the atrio-ventricular (AV)
level remain poorly investigated in patients with dyssynchronised systolic
heart failure (HF). The aim of the present study was to assess the exact prev-
alence and the electrical determinants of AV mechanical dyssynchrony in the
left heart, in this patient population.
Methods: Prospective observational study of 49 HF patients with stable
sinus rhythm and wide QRS complex (mean: 160±19 ms), all scheduled for
CRT device implantation. 12% were in NYHA class II, 85% in NYHA class
III. Mean PR intervall was 200±40 ms, mean LV ejection fraction = 26±5%.
Left AV dyssynchrony (LAVD) was definited as LV filling time (LVFT)
<40% RR interval on transmitral flow at doppler-echocardiography. PR
interval, P wave duration, P’R interval (interval between P wave termination
of and QRS onset), QRS duration and QRS morphology (type of bundle
branch block) were investigated as possible predictors of LAVD. Correlations
between LVFT and ECG intervals were assessed by linear regression.
Results: LAVD was present in 13 patients (26,5). P wave duration, PR
interval and QRS morphology had no predictive value for LAVD. In contrast,
a significant correlation was observed between LVFT and P’R interval
(P<0,005) and QRS duration (p=0,001).
Conclusions: Evidence of resting LAVD is observed in 26,5% patients
with a CRT guideline indication. QRS duration and the P’R interval but not
the PR interval are significant determinants of LAVD. These data may be of
practical importance for optimal programming of CRT devices.
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Introduction: Obstructive sleep apnea (OSA) is associated with several
cardio-vascular abnormalities as atrial fibrillation (AF). AF occurrence in
OSA increases the risk of stroke which worsens the prognosis of these
patients. P wave dispersion (Pd) and maximal P wave duration (P max) are
simple electrocardiographic parameters which reflect atrial conduction abnor-
malities and have been reported to be predictors of atrial fibrillation
Aim: the aim of this study is to determine the correlation between apnea-
hypopnea index (AHI) and P wave dispersion and maximal P wave duration.
Methods: Forty patients (18 men and 22 women) who were diagnosed
with OSA by overnight polysomnography were included in this prospective
study. The mean age was 56±10 years old. They were all in sinus rhythm.
Before initiating continuous positive airway pressure therapy, we evaluated on
a 12 lead ECG P wave duration and P wave dispersion (P max – P min).
Results: Twenty four patients had severe OSA (AHI >30), 4 had moderate
OSA (AHI between 15 and 30) and 12 had a mild OSA (AHI between 5 and
15). Mean P max duration was 119±21 ms. P wave dispersion was 93±6 ms.
There was a significant positive correlation between P max and AHI (r= 0.45,
p=0.001) and between P wave dispersion and AHI (r=0.42, p=0.001)
Conclusion: The severity of OSA seems to be correlated with the impor-
tance of atrial conduction abnormalities. These results suggest the higher is the
AHI the higher is the risk of AF occurrence in OSA. Further studies are
needed to validate these results.
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Background: The Brugada syndrome (BS) is a clinical entity involving
cardiac sodium channelopathy, typical electrocardiogram (ECG) changes and
predisposition to ventricular arrhythmia. This syndrome is mainly recognized
by specialized cardiologists and electrophysiologists. Data regarding BS
largely come from multicentre registries or Asian countries. The objective of
this study was to investigate the clinical characteristics and prognosis of native
Tunisian subjects with the Brugada-type ECG pattern (BS)
Methods and results: BS has been diagnosed in 10 patients (9 men,
1 woman, mean age 38±11 years) at the department of cardiology Sfax since
January 2002. Patients were referred from primary care physicians for ECG
abnormalities, syncope or ventricular arrhythmia, or were diagnosed inciden-
tally on an ECG obtained for other purposes. Nine patients had had an episode
of syncope, dizziness or chest pain, 1 patient was asymptomatic at diagnosis
and any patients survived sudden cardiac death. The electrocardiographics
(ECGs) of all patients showed spontaneous ST-segment elevation in leads V1–3
at baseline and 8 patients (80%) showed transient normalization of the ST-
segment elevation during follow-up. Two patients had a family history of
sudden cardiac death at younger than 45 years of age. No patient has been
found to have a mutation in the SCN5A gene. An implantable cardioverter-
defibrillator was implanted in four patients (40%), including the patient with
a history of syncope. No event occurred in our population after a mean follow-
up of 26±29 months.
Conclusions: BS is present in the Tunisian population and is probably
under-recognized. Long-term prognosis of individuals with BS, especially in
sporadic, asymptomatic cases, needs to be clarified.
